We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$34.9B
1-Year Est. Return
18.88%
This Fund
S&P 500
This Quarter
Est. Return
-5.41%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.6B
AUM Growth
-$55.3B
(-83%)
Cap. Flow
-$52.2B
Cap. Flow
% of AUM
-451.81%
Top 10 Holdings %
Top 10 Hldgs %
17.24%
Holding
2,286
New
72
Increased
349
Reduced
842
Closed
862
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$23.1M |
| 2 |
Workday
WDAY
|
+$23M |
| 3 |
Palo Alto Networks
PANW
|
+$16.6M |
| 4 |
Biogen
BIIB
|
+$16.4M |
| 5 |
Danaher
DHR
|
+$16.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$348M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$342M |
| 3 |
Dollar General
DG
|
+$333M |
| 4 |
Akamai
AKAM
|
+$333M |
| 5 |
Monster Beverage
MNST
|
+$330M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.68% |
| 2 | Technology | 13.63% |
| 3 | Industrials | 12.35% |
| 4 | Financials | 11.99% |
| 5 | Consumer Discretionary | 11.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Vanguard High Dividend Yield ETF
VYM
$82.1B
| $23.5M | 0.2% |
374,356
-22,879
| -6% | -$1.51M |
|
127
Amgen
AMGN
$207B
| $23.4M | 0.2% |
169,355
+16,832
| +11% | +$2.65M |
|
|
ABMD
128
DELISTED
Abiomed Inc
ABMD
| $23.2M | 0.2% |
250,094
-849,561
| -77% | -$74.9M |
|
129
Cooper Companies
COO
$14.4B
| $22.6M | 0.2% |
606,940
-17,796
| -3% | -$738K |
|
|
PINC
130
DELISTED
Premier
PINC
| $22.6M | 0.2% |
656,676
+6,537
| +1% | +$235K |
|
131
Vanguard FTSE Developed Markets ETF
VEA
$233B
| $22.5M | 0.19% |
630,941
-53,488
| -8% | -$2.05M |
|
132
Chevron
CVX
$379B
| $22.3M | 0.19% |
282,650
-32,974
| -10% | -$2.78M |
|
133
3M
MMM
$92B
| $22.3M | 0.19% |
188,032
+11,737
| +7% | +$1.44M |
|
134
McDonald's
MCD
$191B
| $21.9M | 0.19% |
221,911
-7,762
| -3% | -$756K |
|
135
Morningstar
MORN
$7.49B
| $21.6M | 0.19% |
269,477
-209
| -0.1% | -$17.1K |
|
|
HF
136
DELISTED
HFF Inc.
HF
| $21.6M | 0.19% |
640,166
-13,721
| -2% | -$541K |
|
137
Pfizer
PFE
$144B
| $21.3M | 0.18% |
715,047
+4,135
| +0.6% | +$133K |
|
138
Walmart Inc
WMT
$874B
| $21.1M | 0.18% |
976,887
-1,599
| -0.2% | -$36.7K |
|
139
J.M. Smucker
SJM
$12.6B
| $20.7M | 0.18% |
181,798
-2,239
| -1% | -$250K |
|
140
Ziff Davis
ZD
$2.02B
| $20.3M | 0.18% |
329,897
-2,810,721
| -89% | -$170M |
|
141
ManpowerGroup
MAN
$2.5B
| $20.3M | 0.18% |
247,621
-652,070
| -72% | -$58.1M |
|
142
Blackrock
BLK
$176B
| $20M | 0.17% |
67,345
-8,319
| -11% | -$2.68M |
|
|
143
PayPal
PYPL
$49.7B
| $20M | 0.17% |
+644,428
| New | +$23.1M |
|
|
GMCR
144
DELISTED
KEURIG GREEN MTN INC
GMCR
| $19.9M | 0.17% |
381,256
-1,353,208
| -78% | -$83.3M |
|
145
Novartis
NVS
$292B
| $19.7M | 0.17% |
238,775
+9,748
| +4% | +$868K |
|
146
Encore Capital Group
ECPG
$2.06B
| $19.5M | 0.17% |
527,494
-2,525,925
| -83% | -$103M |
|
147
Invesco
IVZ
$14B
| $19.2M | 0.17% |
616,021
+12,940
| +2% | +$460K |
|
148
BorgWarner
BWA
$12.8B
| $19M | 0.16% |
519,026
-4,202,095
| -89% | -$175M |
|
|
PCP
149
DELISTED
PRECISION CASTPARTS CORP
PCP
| $18.9M | 0.16% |
82,367
-205,610
| -71% | -$44.1M |
|
150
Philip Morris
PM
$288B
| $18.8M | 0.16% |
237,486
+3,359
| +1% | +$276K |
|
Similar funds
SAM
VIA
William Blair & Company's Q3 2015 Portfolio in Review
As of Q3 2015, William Blair & Company held 2,286 positions worth $11.6B, down 83% from $66.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
William Blair & Company withdrew a net $52.2B in Q3 2015, closing 862 positions and reducing 842 holdings. Its most notable exit was Enbridge, an estimated $154M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 7.4% a quarter earlier, followed by Technology and Industrials.
Against the trend, William Blair & Company opened a new position in PayPal worth $20M.
- William Blair & Company's largest Q3 2015 buy was PayPal: 644,428 shares worth $20M.
- William Blair & Company added most to Workday in Q3 2015, an estimated $23M increase.
- William Blair & Company's biggest Q3 2015 reduction was Teva Pharmaceuticals, cutting an estimated $348M.
- William Blair & Company fully exited Enbridge in Q3 2015, selling an estimated $154M.
- William Blair & Company's ten largest holdings make up 17% of its $11.6B portfolio in Q3 2015.
- William Blair & Company opened 72 new positions and closed 862 in Q3 2015.
- William Blair & Company's portfolio value fell 83% quarter-over-quarter to $11.6B.
Based on William Blair & Company's 13F filing for Q3 2015, filed 12 Nov 2015.